Worth your time

The dark-money ads opposing legislation to rein in surprise medical billing are funded by private equity firms that staff emergency rooms across the U.S., the New York Times writes. — Lev Facher

Drug makers would rather stick with FDA review than use a so-called right-to-try pathway to help people with life-threatening illnesses get access to experimental treatments, according to STAT. — Erin Mershon

Kaiser Health News has an eye-opening new dispatch on the rise of smuggled — and often counterfeit — drugs, particularly in immigrant communities.  — Nicholas Florko